跳至主要内容
临床试验/NCT00631514
NCT00631514已完成4 期

Relevance of the Interaction Between Antihypertensive and Antirheumatic Drugs in a Family Practice

University Hospital of Split1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2005年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
88
试验地点
1
主要终点
Arterial blood pressure

研究概览

简要总结

NSAIDs may increase blood pressure and blunt the effects of many antihypertensives. Members of these drug classes differ in their propensity to such an interaction.

详细描述

To compare prospectively the effects of piroxicam, ibuprofen and acetaminophen on blood pressure control in hypertensive patients with osteoarthritis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
55 Years 至 78 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Treated hypertensives of either gender aged between 55 and 76 years
  • About 50% with concomitant osteoarthritis of the hip or knee

排除标准

  • Normotensive persons or untreated hypertensives
  • Individuals outside the age limits
  • General exclusion criteria (e.g. uncooperative persons, advanced malignancies, participants in other studies)

研究组 & 干预措施

2

Experimental

Intervention: NSAID. Hypertensives with osteoarthritis taking already amlodipine (5-10 mg o.d. per os) were randomized to the following drug interventions: to take either acetaminophen (1000 mg t.i.d. per os), piroxicam (10-20 mg o.d. per os) or ibuprofen (400-600 mg t.i.d. per os) for 1 month

干预措施: acetaminophen (Drug)

2

Experimental

Intervention: NSAID. Hypertensives with osteoarthritis taking already amlodipine (5-10 mg o.d. per os) were randomized to the following drug interventions: to take either acetaminophen (1000 mg t.i.d. per os), piroxicam (10-20 mg o.d. per os) or ibuprofen (400-600 mg t.i.d. per os) for 1 month

干预措施: ibuprofen (Drug)

2

Experimental

Intervention: NSAID. Hypertensives with osteoarthritis taking already amlodipine (5-10 mg o.d. per os) were randomized to the following drug interventions: to take either acetaminophen (1000 mg t.i.d. per os), piroxicam (10-20 mg o.d. per os) or ibuprofen (400-600 mg t.i.d. per os) for 1 month

干预措施: piroxicam (Drug)

3

Experimental

Hypertensives with osteoarthritis taking already lisinopril/hydrochlorothiazide (20/12.5 mg o.d. per os), were sequentially randomized to the following drug interventions: acetaminophen (1000 mg t.i.d.), ibuprofen (400-600 mg t.i.d.) or piroxicam (10-20 mg o.d.), for 1 month each

干预措施: acetaminophen (Drug)

3

Experimental

Hypertensives with osteoarthritis taking already lisinopril/hydrochlorothiazide (20/12.5 mg o.d. per os), were sequentially randomized to the following drug interventions: acetaminophen (1000 mg t.i.d.), ibuprofen (400-600 mg t.i.d.) or piroxicam (10-20 mg o.d.), for 1 month each

干预措施: ibuprofen (Drug)

3

Experimental

Hypertensives with osteoarthritis taking already lisinopril/hydrochlorothiazide (20/12.5 mg o.d. per os), were sequentially randomized to the following drug interventions: acetaminophen (1000 mg t.i.d.), ibuprofen (400-600 mg t.i.d.) or piroxicam (10-20 mg o.d.), for 1 month each

干预措施: piroxicam (Drug)

结局指标

主要结局

Arterial blood pressure

时间窗: 3 months (3 individual blocks of 1 month each)

次要结局

  • Body weight,serum electrolytes, urinary electrolytes (Na, K)(3 months (3 periods of 1 month))

研究者

发起方
University Hospital of Split
申办方类型
Other

研究点 (1)

Loading locations...

相似试验